An investor group that includes One Rock Capital Partners LLC, Laurel Crown Partners, StoneCreek Capital and management purchased Kova International from Hycor Biomedical Inc.

Kova, headquartered in Garden Grove, Calif., develops and manufactures in-vitro diagnostic products. Hycor manufactures and markets diagnostic products used in clinical laboratories. Terms of the deal were not disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.